aztreonam has been researched along with Fever in 20 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Fever: An abnormal elevation of body temperature, usually as a result of a pathologic process.
Excerpt | Relevance | Reference |
---|---|---|
"The efficacy and safety of piperacillin/tazobactam plus ceftazidime (PIPC/TAZ+CAZ) versus sulbactam/ampicillin plus aztreonam (SBT/ABPC+AZT) as empirical therapy for febrile neutropenia were assessed in children with hematologic disease and solid tumor." | 9.14 | Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients. ( Iguchi, A; Kaneda, M; Kobayashi, R; Nakajima, M; Sato, T, 2009) |
" In the present study, we chose aztreonam as the alternative to aminoglycoside in combination with piperacillin for neutropenic fever in pediatric patients and we evaluated its effectiveness." | 9.10 | Piperacillin plus aztreonam for treatment of neutropenic fever. ( Mayumi, M; Takeuchi, M; Tanizawa, A, 2003) |
"Fourty-two febrile episodes of 32 patients with hematologic disease during neutropenia were treated with two randomly assigned antibiotic combinations of either piperacillin plus gentamicin or piperacillin plus aztreonam." | 9.07 | [Aztreonam or gentamicin combined with piperacillin as empiric antibiotic therapy during neutropenia of patients with hematologic diseases]. ( Murase, T, 1992) |
"The efficacy of aztreonam in combination with vancomycin was compared with that of gentamicin plus piperacillin as empirical antibiotic treatment for fever in 61 neutropenic patients." | 9.07 | Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study. ( Kelsey, SM; Newland, AC; Shaw, E, 1992) |
" We evaluated the efficacy of a combined antibiotic regimen of monobactam (aztreonam) and antipseudomonal penicillin (piperacillin) in treating neutropenic fever episodes in gynecologic-oncology patients receiving cisplatin-based chemotherapy." | 7.70 | Aztreonam plus piperacillin--empiric treatment of neutropenic fever in gynecology-oncology patients receiving cisplatin-based chemotherapy. ( Altaras, M; Beyth, Y; Chowers, M; Fishman, A; Lang, R, 1998) |
"The efficacy and safety of piperacillin/tazobactam plus ceftazidime (PIPC/TAZ+CAZ) versus sulbactam/ampicillin plus aztreonam (SBT/ABPC+AZT) as empirical therapy for febrile neutropenia were assessed in children with hematologic disease and solid tumor." | 5.14 | Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients. ( Iguchi, A; Kaneda, M; Kobayashi, R; Nakajima, M; Sato, T, 2009) |
" In the present study, we chose aztreonam as the alternative to aminoglycoside in combination with piperacillin for neutropenic fever in pediatric patients and we evaluated its effectiveness." | 5.10 | Piperacillin plus aztreonam for treatment of neutropenic fever. ( Mayumi, M; Takeuchi, M; Tanizawa, A, 2003) |
"Fourty-two febrile episodes of 32 patients with hematologic disease during neutropenia were treated with two randomly assigned antibiotic combinations of either piperacillin plus gentamicin or piperacillin plus aztreonam." | 5.07 | [Aztreonam or gentamicin combined with piperacillin as empiric antibiotic therapy during neutropenia of patients with hematologic diseases]. ( Murase, T, 1992) |
"The efficacy of aztreonam in combination with vancomycin was compared with that of gentamicin plus piperacillin as empirical antibiotic treatment for fever in 61 neutropenic patients." | 5.07 | Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study. ( Kelsey, SM; Newland, AC; Shaw, E, 1992) |
" Thus, both the adverse prognostic effect of leukemia as an underlying disease and the poorer results obtained using aztreonam-containing regimens were evident only with certain outcome definitions." | 5.06 | The effect of different measures of outcome on the results of studies of empiric antibiotic therapy in febrile neutropenic patients. ( Elliott, CR; Pater, JL, 1988) |
" We evaluated the efficacy of a combined antibiotic regimen of monobactam (aztreonam) and antipseudomonal penicillin (piperacillin) in treating neutropenic fever episodes in gynecologic-oncology patients receiving cisplatin-based chemotherapy." | 3.70 | Aztreonam plus piperacillin--empiric treatment of neutropenic fever in gynecology-oncology patients receiving cisplatin-based chemotherapy. ( Altaras, M; Beyth, Y; Chowers, M; Fishman, A; Lang, R, 1998) |
"There was one infection-related death among patients assigned to AAT therapy and also one among those assigned to LAT therapy." | 2.66 | [Empiric therapy with aztreonam for febrile neutropenic patients with hematological malignancies]. ( Ichimaru, M; Moriuchi, Y; Soda, H; Tomonaga, M; Toriya, K, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (25.00) | 18.7374 |
1990's | 12 (60.00) | 18.2507 |
2000's | 3 (15.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kobayashi, R | 1 |
Sato, T | 1 |
Nakajima, M | 1 |
Kaneda, M | 1 |
Iguchi, A | 1 |
Fleming, DR | 1 |
Ziegler, C | 1 |
Baize, T | 1 |
Mudd, L | 1 |
Goldsmith, GH | 1 |
Herzig, RH | 1 |
Takeuchi, M | 1 |
Tanizawa, A | 1 |
Mayumi, M | 1 |
Rubenstein, EB | 1 |
Rolston, K | 1 |
Benjamin, RS | 1 |
Loewy, J | 1 |
Escalante, C | 1 |
Manzullo, E | 1 |
Hughes, P | 1 |
Moreland, B | 1 |
Fender, A | 1 |
Kennedy, K | 1 |
Raad, II | 1 |
Whimbey, EE | 1 |
Rolston, KV | 1 |
Abi-Said, D | 1 |
Hachem, RY | 1 |
Pandya, RG | 1 |
Ghaddar, HM | 1 |
Karl, CL | 1 |
Bodey, GP | 1 |
Fishman, A | 1 |
Chowers, M | 1 |
Altaras, M | 1 |
Beyth, Y | 1 |
Lang, R | 1 |
Zingman, BS | 1 |
Murase, T | 1 |
Bosi, A | 1 |
Fanci, R | 1 |
Pecile, P | 1 |
Guidi, S | 1 |
Saccardi, R | 1 |
Vannucchi, AM | 1 |
Longo, G | 1 |
Donnini, E | 1 |
Orsi, A | 1 |
Rossi-Ferrini, P | 1 |
Kelsey, SM | 1 |
Shaw, E | 1 |
Newland, AC | 1 |
Heney, D | 1 |
Lewis, IJ | 1 |
Ghoneim, AT | 1 |
Chisholm, P | 1 |
Bailey, CC | 1 |
Bodey, G | 1 |
Reuben, A | 1 |
Elting, L | 1 |
Kantarjian, H | 1 |
Keating, M | 1 |
Hagemeister, F | 1 |
Koller, C | 1 |
Velasquez, W | 1 |
Papadopoulos, N | 1 |
Hirotsu, T | 1 |
Akatsuka, J | 1 |
Hoshi, Y | 1 |
Uchiyama, H | 1 |
Fujisawa, K | 1 |
Kobayashi, N | 1 |
Ishidoya, N | 1 |
Ohira, M | 1 |
Takayama, J | 1 |
Ishida, Y | 1 |
Rubin, M | 2 |
Walsh, T | 1 |
Butler, K | 1 |
Lee, J | 1 |
Lecciones, J | 1 |
Weinberger, M | 1 |
Roilides, E | 1 |
Gress, J | 1 |
Marshall, D | 1 |
Pizzo, PA | 2 |
Moriuchi, Y | 1 |
Soda, H | 1 |
Toriya, K | 1 |
Tomonaga, M | 1 |
Ichimaru, M | 1 |
Natali, M | 1 |
Tonini, G | 1 |
Tufo, E | 1 |
Leggio, M | 1 |
Carassai, A | 1 |
Lopez, M | 1 |
Elliott, CR | 1 |
Pater, JL | 1 |
Menichetti, F | 1 |
Bucaneve, G | 1 |
Patoia, L | 1 |
Guerciolini, R | 1 |
Minotti, V | 1 |
Pauluzzi, S | 1 |
Del Favero, A | 1 |
Lagast, H | 1 |
Klastersky, J | 1 |
Kains, JP | 1 |
van der Auwera, P | 1 |
Meunier, F | 1 |
Woussen, F | 1 |
Thijs, JP | 1 |
1 review available for aztreonam and Fever
Article | Year |
---|---|
The febrile neutropenic patient: newer options for empirical therapy.
Topics: Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Carbapenems; Cephalosporins | 1990 |
15 trials available for aztreonam and Fever
Article | Year |
---|---|
Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Ceftazidime; Child; Child, P | 2009 |
Cefepime versus ticarcillin and clavulanate potassium and aztreonam for febrile neutropenia therapy in high-dose chemotherapy patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Aztreonam; Cefepime; Cephalosporins; Clav | 2003 |
Piperacillin plus aztreonam for treatment of neutropenic fever.
Topics: Adolescent; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Child; Child, Preschool; Drug Th | 2003 |
Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ambulatory Care; Aztreonam; Bacteremia; Bacterial Inf | 1993 |
A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; | 1996 |
[Aztreonam or gentamicin combined with piperacillin as empiric antibiotic therapy during neutropenia of patients with hematologic diseases].
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Aztreonam; Bacterial Infections; Cefamandole; Drug Therap | 1992 |
Aztreonam versus colistin-neomycin for selective decontamination of the digestive tract in patients undergoing bone marrow transplantation: a randomized study.
Topics: Aztreonam; Bone Marrow Transplantation; Colistin; Digestive System Diseases; Drug Therapy, Combinati | 1992 |
Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study.
Topics: Adult; Aztreonam; Bacteremia; Drug Therapy, Combination; Fever; Gentamicins; Gram-Negative Bacteria; | 1992 |
Aztreonam therapy in children with febrile neutropenia: a randomized trial of aztreonam plus flucloxacillin versus piperacillin plus gentamicin.
Topics: Adolescent; Aztreonam; Bacteremia; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever | 1991 |
Comparison of two schedules of cefoperazone plus aztreonam in the treatment of neutropenic patients with fever.
Topics: Aztreonam; Bacterial Infections; Cefoperazone; Drug Administration Schedule; Drug Therapy, Combinati | 1991 |
[Clinical evaluation of aztreonam for infections accompanying febrile neutropenic children with hematologic disorders and solid tumors. A cooperative study].
Topics: Adolescent; Age Factors; Aztreonam; Bacterial Infections; Cefmetazole; Child; Child, Preschool; Drug | 1990 |
[Empiric therapy with aztreonam for febrile neutropenic patients with hematological malignancies].
Topics: Aztreonam; Drug Evaluation; Drug Therapy, Combination; Fever; Humans; Infections; Leukemia; Lymphoma | 1989 |
The effect of different measures of outcome on the results of studies of empiric antibiotic therapy in febrile neutropenic patients.
Topics: Acute Disease; Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Clinical Trials as Topic; Cloxacil | 1988 |
Aztreonam plus cefazolin: a double beta-lactam combination as empirical therapy in febrile cancer patients with or without granulocytopenia.
Topics: Agranulocytosis; Aztreonam; Bacterial Infections; Cefazolin; Ceftriaxone; Clinical Trials as Topic; | 1987 |
Empiric antimicrobial therapy with aztreonam or ceftazidime in gram-negative septicemia.
Topics: Adult; Aged; Aztreonam; Blood Bactericidal Activity; Ceftazidime; Enterobacteriaceae Infections; Fem | 1986 |
4 other studies available for aztreonam and Fever
Article | Year |
---|---|
Aztreonam plus piperacillin--empiric treatment of neutropenic fever in gynecology-oncology patients receiving cisplatin-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aztreonam; Bacterial | 1998 |
Fever after cytotoxic therapy of chronic lymphocytic leukemia.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Aztreonam; Candidiasis; Female; | 1999 |
Monotherapy for empirical management of febrile neutropenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Costs and Cost Analysis; Fever; H | 1990 |
[Aztreonam and oxacillin in the treatment of febrile neutropenic patients with solid tumors].
Topics: Adult; Aged; Agranulocytosis; Aztreonam; Bacterial Infections; Female; Fever; Humans; Male; Middle A | 1989 |